RecruitingNot ApplicableNCT06291818

Self-Adhering Magnetic Device to Treat Corneal Exposure


Sponsor

University of Illinois at Chicago

Enrollment

25 participants

Start Date

Apr 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Males and females ages 18-80 years old.
  • Patients with recent corneal abrasion and no signs of infection in the examination
  • Patients with lagophthalmos
  • Normal Controls

Exclusion Criteria3

  • Individuals with adhesive or tape allergies.
  • Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking)
  • Individuals with eye infections

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtemporary magnetic system for tarsorrhaphy (MST)

cutting-edge technology has produced smaller magnets with stronger magnetic fields, prompting experts to revisit the use of magnets to facilitate eyelid closure


Locations(1)

University of Illinois - Specialty Care Building

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06291818


Related Trials